SPESOLIMAB-SBZO for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 7 adverse event reports in the FDA FAERS database where SPESOLIMAB-SBZO was used for Psoriasis.
Most Reported Side Effects for SPESOLIMAB-SBZO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Generalised pustular psoriasis | 29 | 14.7% | 1 | 3 |
| Drug ineffective | 20 | 10.1% | 0 | 1 |
| Rash | 14 | 7.1% | 0 | 1 |
| Pruritus | 13 | 6.6% | 0 | 1 |
| Fatigue | 11 | 5.6% | 0 | 0 |
| Psoriasis | 10 | 5.1% | 0 | 2 |
| Pustule | 9 | 4.6% | 0 | 0 |
| Headache | 7 | 3.5% | 0 | 0 |
| Urinary tract infection | 7 | 3.5% | 1 | 4 |
| Arthralgia | 6 | 3.0% | 0 | 1 |
| Condition aggravated | 6 | 3.0% | 0 | 0 |
| Intentional product use issue | 6 | 3.0% | 0 | 0 |
| Maternal exposure during pregnancy | 6 | 3.0% | 0 | 0 |
| Off label use | 6 | 3.0% | 0 | 2 |
| Peripheral swelling | 6 | 3.0% | 0 | 1 |
Other Indications for SPESOLIMAB-SBZO
Generalised pustular psoriasis (80)
Pustular psoriasis (70)
Product used for unknown indication (36)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)